You see this nTMS everywhere now, both in Finland and elsewhere, so it would be a surprise if this doesn’t benefit the manufacturer of the best device as well. Diamond hands and it will turn out well 
So we are starting to move into the Early Adoption phase:
I don’t believe that even 2.5% of the user base has been reached yet.
“When creating each treatment plan, multimodal neurodiagnostics are taken into account, including MRI, diffusion tensor imaging, EEG or quantitative EEG, as well as neurocognitive assessment. This information is integrated into Nexstim’s neuronavigation environment to guide individual targeting and the selection of the treatment protocol. This enables consistent, reproducible stimulation of the patient’s individual cortical areas and brain networks, especially in complex neuropsychiatric and neurotraumatic cases.”
I suppose that’s the core of it, and why Sinaptica also chose Nexstim. In other words, the precision of the stimulation is everything.